Evidence map›Paper›PMID 26458779›Full record

ReviewThe American journal of tropical medicine and hygiene2015

A Review of Melioidosis Cases in the Americas.

Tina J Benoit, David D Blaney, Thomas J Doker, Jay E Gee, Mindy G Elrod, Dionne B Rolim, Timothy J J Inglis, Alex R Hoffmaster, William A Bower, Henry T Walke

Open access · bronzeAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in The American journal of tropical medicine and hygiene, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 1 pooled it
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 1 synthesis or guideline pooled it, 77 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Occupational Laboratory Exposures toPathogens (Basel, Switzerland) · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Melioidosis in Cynomolgus Macaques (Comparative medicine · 2022
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Tina J BenoitBacterial Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia; Universidade de Fortaleza (UNIFOR), Fortaleza, Brazil; School of Pathology and Laboratory Medicine, University of Western Australia, Western Australia, Australia.
David D BlaneyBacterial Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia; Universidade de Fortaleza (UNIFOR), Fortaleza, Brazil; School of Pathology and Laboratory Medicine, University of Western Australia, Western Australia, Australia dblaney@cdc.gov.
Thomas J DokerBacterial Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia; Universidade de Fortaleza (UNIFOR), Fortaleza, Brazil; School of Pathology and Laboratory Medicine, University of Western Australia, Western Australia, Australia.
Jay E GeeBacterial Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia; Universidade de Fortaleza (UNIFOR), Fortaleza, Brazil; School of Pathology and Laboratory Medicine, University of Western Australia, Western Australia, Australia.
Mindy G ElrodBacterial Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia; Universidade de Fortaleza (UNIFOR), Fortaleza, Brazil; School of Pathology and Laboratory Medicine, University of Western Australia, Western Australia, Australia.
Dionne B RolimBacterial Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia; Universidade de Fortaleza (UNIFOR), Fortaleza, Brazil; School of Pathology and Laboratory Medicine, University of Western Australia, Western Australia, Australia.
Timothy J J InglisBacterial Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia; Universidade de Fortaleza (UNIFOR), Fortaleza, Brazil; School of Pathology and Laboratory Medicine, University of Western Australia, Western Australia, Australia.
Alex R HoffmasterBacterial Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia; Universidade de Fortaleza (UNIFOR), Fortaleza, Brazil; School of Pathology and Laboratory Medicine, University of Western Australia, Western Australia, Australia.
William A BowerBacterial Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia; Universidade de Fortaleza (UNIFOR), Fortaleza, Brazil; School of Pathology and Laboratory Medicine, University of Western Australia, Western Australia, Australia.
Henry T WalkeBacterial Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia; Universidade de Fortaleza (UNIFOR), Fortaleza, Brazil; School of Pathology and Laboratory Medicine, University of Western Australia, Western Australia, Australia.
Centers for Disease Control and Prevention · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Melioidosis is a bacterial infection caused by Burkholderia pseudomallei, a gram-negative saprophytic bacillus. Cases occur sporadically in the Americas with an increasing number of cases observed among people with no travel history to endemic countries. To better understand the incidence of the disease in the Americas, we reviewed the literature, including unpublished cases reported to the Centers for Disease Control and Prevention. Of 120 identified human cases, occurring between 1947 and June 2015, 95 cases (79%) were likely acquired in the Americas; the mortality rate was 39%. Burkholderia pseudomallei appears to be widespread in South, Central, and North America.

Indexed as

Burkholderia pseudomalleiCaribbean RegionCentral AmericaHumansIncidenceMelioidosisNorth AmericaSouth America

Identifiers

PMID26458779
PMCPMC4674224
OpenAlexW2263967633

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.